Fangzheng Securities Underwriting and Sponsorship Co., Ltd. report on the 2024 semi-annual continuous supervision and follow-up report of Shanghai Sailun Biotechnology Co., Ltd.
Syren Biotech: 2024 Semi-Annual Equity Distribution Implementation Notice
Syren Biotech: Announcement on the 2024 Semi-Annual Profit Distribution Plan
Syren Biotech: Special Report on the Storage and Actual Use of Funds Raised for the Semi-Annual Year 2024
Syren Biotech: Semi-Annual Evaluation Report on the 2024 “Improve Quality, Increase Efficiency, and Value Rewards” Action Plan
Syren Biotech: 2024 Semi-Annual Report
Syren Biotech: 2024 Semi-Annual Report Summary
Syren Biotech: Announcement of Resolutions of the 16th Meeting of the 3rd Board of Supervisors
Legal opinion from JinTianCheng Law Firm, Shanghai, regarding the shareholding of one of the actual controlling persons, directors, general managers, and some senior management personnel of Shanghai Cellon Biotechnology Co., Ltd.
Shanghai Serum Bio-Technology: Announcement of the completion of the implementation of the shareholding plan for one of the actual controllers, directors, general managers, and some senior management personnel, as well as the results of the shareholding increase.
Shanghai Serum Bio-Technology: Notice on the postponement of the board of directors and supervisory board's session for re-election.
Shanghai Serum Bio-Technology: Announcement regarding the proposal for interim dividends in 2024 by one of the actual controlling shareholders and chairman, and the implementation of the "improving quality and efficiency, and returning value" action plan.
Shanghai Serum Bio-Technology: 2023 Annual Equity Distribution Implementation Notice
Fangzheng Securities Underwriting and Sponsorship Co., Ltd. report on the 2023 continuous supervision and follow-up report of Shanghai Sailun Biotechnology Co., Ltd.
Shanghai Serum Bio-Technology: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Shanghai AllBright Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Serun Biotechnology Co., Ltd.
Shanghai Serum Bio-Technology: Announcement on attending the 2023 Biological Products Special Group Results Briefing and the 2024 First Quarter Results Briefing
Shanghai Serum Bio-Technology: 2023 Annual General Meeting of Shareholders Meeting Materials
Tianji International Accounting Firm (Special General Partnership) Verification Report on the Storage and Actual Use of Funds Raised by Syren Biotech
Shanghai Serum Bio-Technology: Special report on the storage and actual use of funds raised in 2023
No Data